🔎 Trials Near Me

Beranda › Sarkoma Jaringan Lunak › Ohio › Columbus

Uji klinis Sarkoma Jaringan Lunak di Columbus, OH

13 studi untuk Sarkoma Jaringan Lunak mencari peserta di lokasi sekitar Columbus (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

Menerima pesertaFase 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06528769

Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

Menerima pesertaFase 1/2
  • Nationwide Children's Hospital, Columbus
Usia 12 hingga 40 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07725380

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • The Mark H Zangmeister Center, Columbus
  • dan 8 lainnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05334069

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

Menerima pesertaFase 3
  • The James Cancer Hospital and Solove Research Institute, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06263231

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Menerima pesertaStudi observasional
  • OSU James Hospital, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT07377747

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Menerima pesertaFase 1/2
  • Ohio State University, Columbus
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06710756

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Menerima pesertaFase 1/2
  • The Ohio State University Wexner Medical Center, Columbus
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT03093116

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Menerima pesertaStudi observasional
  • Ohio State University, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Feb 2026 · NCT02677961

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Menerima pesertaFase 1/2
  • Nationwide Children's Hospital, Columbus
Usia 2 hingga 30 · Semua jenis kelamin · Diperbarui 3 Feb 2026 · NCT05734066

68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas

Menerima peserta
  • Ohio State University Comprehensive Cancer Center, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Feb 2026 · NCT06500065

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Menerima pesertaFase 1/2
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Des 2025 · NCT06943521

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Menerima pesertaFase 2
  • Nationwide Children's Hospital, Columbus
18 Months – 40 Years · Semua jenis kelamin · Diperbarui 12 Agu 2025 · NCT05135975

REtroperitoneal SArcoma Registry: an International Prospective Initiative

Menerima pesertaStudi observasional
  • The Ohio State University, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Feb 2019 · NCT03838718

Uji klinis Sarkoma Jaringan Lunak di kota lain

Studi lain di Columbus

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.